openPR Logo
Press release

Chemotherapy Induced Anemia Market to register a healthy CAGR for the forecast period, 2016-2026

06-29-2017 03:41 PM CET | Health & Medicine

Press release from: Future Market Insights

Chemotherapy Induced Anemia Market to register a healthy CAGR

Anemia is a most common hematologic disorder in majority of cancer patients receiving chemotherapy treatment. Anemia is a condition in which person do not have sufficient red blood cells in the body or low ability of hemoglobin to carry oxygen and circulate it to all cells in the body. Anemia can be caused by cancer treatment, low iron levels in body, organ problems, chronic kidney disease and thalassemia. Moreover, some other risk factors that can develop anemia among cancer patients are namely platinum based chemotherapy, low level of red blood cells before having cancer and certain tumor type. To find out the cause of anemia certain tests need to be done such as blood chemistry tests, reticulocyte count, stool test and bone marrow exam. In Europe, the study has been conducted by European Cancer Anemia Survey (ECAS) across 24 nations stated that around 83% of the patients going for chemotherapy demonstrated anemia disorder. Anemia often exhibit symptoms such as fatigue, dyspnea, chest pain and fast heartbeat. It has been estimated that about 50% of the cancer patients suffering from anemia did not received any treatment. However, patients with head and neck cancer suffering from anemia have risk of death is around 19% and 47% with prostate cancer patients.

Chemotherapy Induced Anemia Market:Drivers and Restraints

Chemotherapy induced anemia market are witnessing maximum growth owing to increase in the prevalence of cancer and anemia among geriatric patients, bone marrow invasion, increase in pipeline products, advancement in the technology, reimbursement policy and increase in chronic inflammatory conditions. Moreover, side effects of the cancer treatment can develop anemia and increase in various etiologies of anemia in cancer patients are some other factors expected to flourish the chemotherapy induced anemia market. However, side effects of drugs, increase in the mortality rate and risk associated with treatment may hamper the growth of chemotherapy induced anemia market in near future.

Request For Report Sample@

Chemotherapy Induced Anemia Market:Segmentation

The chemotherapy induced anemia market has been classified on the basis of range of anemia, treatment type, drug type and end user.

Based on rang of anemia, the chemotherapy induced anemia market is segmented into the following:

Mild Anemia

Moderate Anemia

Severe Anemia

Life-threatening Anemia

Based on treatment type, the chemotherapy induced anemia market is segmented into the following:

RBC Transfusions

Erythropoiesis-stimulating agents (ESAs)

Iron Supplementation

Based on drug type, the chemotherapy induced anemia market is segmented into the following:

Epogen Injection

Procrit Injection

Androxy Oral

Aranesp injection

Epoetin Alfa Injection


Based on end-user, the chemotherapy induced anemia market is segmented into the following:


Ambulatory Surgical Centers

Multispecialty Clinics

Cancer Research Centers

Cancer Rehabilitation Centers

Chemotherapy Induced Anemia Market:Overview

In Japan, cancer patients with anemia disorder are treated with RBC transfusions. On the other hand, in USA and Europe patients with chemotherapy induced anemia are treated with erythropoiesis stimulating agents namely epoetin & darbepoetin. Fatigue is the most severe symptoms of chemotherapy induced anemia among cancer patients and experience fatigue in moderate to severe range of anemia. Patients received platinum, gemcitabine and anthracycline based regimens has high chances of develop anemia.

Chemotherapy Induced Anemia Market: Region-wise Outlook

Depending on geographic region, Chemotherapy Induced Anemia Market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. Asia Pacific dominates the chemotherapy induced anemia marketfollowed by Europe, Japan and North America owing to high awareness of disease among population, government initiatives, great advancement in the field of chemotherapy induced anemia and developed healthcare infrastructure in these regions. Asia Pacific, Middle East and Africa hold huge potential and shows substantial growth in terms of wide acceptance of new technologyowing to high mortality rate, prevalence of anemia among cancer patients, increasing healthcare expenditure and high potential customer base need treatment for chemotherapy induced anemia.

Visit For TOC@

Chemotherapy Induced Anemia Market:Key Players

Key players of Chemotherapy Induced Anemia Marketare Dr. Reddy’s Laboratories Ltd., Pfizer Inc., SBI Pharmaceuticals Co., Ltd, Panacea Biotec Limited, Panacea Biotec., 3SBio Inc., Tolero Pharmaceuticals, Inc., Vifor Pharma AG and Therapure Biopharma Inc.

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chemotherapy Induced Anemia Market to register a healthy CAGR for the forecast period, 2016-2026 here

News-ID: 602257 • Views: 145

More Releases from Future Market Insights

How Changing Dynamics of Cable Testing Market are Reflecting on Growth Strategie …
Global Cable Testing Market: Introduction The cost of the substitution of cables that are concealed is very high. Faults in the cable, bending, kinking, and crushing, are not always visible, which has created the requirement for cable testing. Thus, cable testing helps check the cable functionality, cable quality, and cable conformity. Several times, cable testing by visual inspection is an effective way of identifying the actual problem before it causes any
How Transformative Trends in Self-Organising Network Market are Molding Strategi …
Self-Organising Network: Introduction With accelerated advancements and increasing complexities in the radio network technologies, such as those utilised for the development of LTE and 5G networks, which are used for planning, management, configuration, healing and optimisation, are required to be automated to facilitate efficiency. At present, suppliers are offering self-organising networks that possess the ability to offer optimum performance. Self-organising networks are use cases that perform network governance, including network planning,
Mining Vehicle AC Kits Market: Exploring the Impact of Trends on Strategies of K …
Mining Vehicle AC Kits Market: Introduction Cabin space in mining equipment has become more sophisticated in the recent past. The installation of mining vehicle AC kits has evolved from an optional feature to a necessary feature. Mining equipment manufacturers have made advancements in technology related to efficiency, performance and cost of air conditioning systems in order to make them affordable and economical to enable low-budget and compact installations without compromising on
Key Factors to Fuel Growth of the Talent Acquisition & Staffing Technology and S …
With the growing importance of recruiting and retaining top talent effectively and efficiently, smart hiring processes are the need of the hour. It is about time organisations move beyond merely scrutinising resumes. Salaries and benefits are important factors, but adopting ways that would make candidates an important part of the hiring process will attract the best talent. Studies reveal that due to discrepancies in existing Applicant Tracking Systems (ATS), hiring

All 5 Releases

More Releases for Anemia

Global Acquired Aplastic Anemia Market Insights, Forecast
Acquired aplastic anemia is a rare, serious blood disorder, due to failure of the bone marrow failure to produce blood cells. Bone marrow is the spongy substance found in the center of the bones of the body, in adults mainly the spine, pelvis, and large bones of the legs. The global Acquired Aplastic Anemia market is valued at xx million US$ in 2018 and will reach xx million US$ by
Global Anemia Drugs and Companies Review 2022
Report Description This report analyzes the global anemia drugs market by anemia type (iron deficiency anemia, sickle cell anemia, aplastic anemia, hemolytic anemia, pernicious anemia and others), by route of administration (oral and injectable), by product type (biologics and non-biologics), end user (hospitals and self-administered); it also studies the top manufacturers in the market. GET SAMPLE REPORT @ The global anemia drugs market is expected to be around USD 21.4
Anemia Drugs Market 2018 Grow at CAGR of 8.4% to Reach USD 34.7 Billion | By Uni …
Market Research Future Published a Prime research Report on “Global Anemia Drugs Market Research Report - Forecast to 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022 Global Anemia Drugs Market - Segments Global anemia drugs market has been segmented on the basis of anemia type which comprises iron deficiency anemia, sickle cell anemia, aplastic anemia, hemolytic anemia pernicious anemia and others. On the basis of route of administration;
Anemia Drugs Market 2022: Complete Research Report
Market research future published a half-cooked research report on global Anemia Drugs market. The global Anemia Drugs market is expected to grow at a CAGR of 8.4% during the period 2016 to 2022. The Global Anemia Drugs Market is expected to be around US$21.4 billion and is expected to grow at a CAGR of 8.4% to reach US$34.7 billion by the end of forecast period. Anemia is one of the most common
Chemotherapy Induced Anemia - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Chemotherapy Induced Anemia - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Anemia - Pipeline Review, H2 2017, provides an overview of the Chemotherapy Induced Anemia (Toxicology) pipeline landscape. Chemotherapy-induced anemia is a very common side effect of cancer treatment. Symptoms include severe fatigue, weakness,
Global Anemia Drugs Market - Growth after 2017
This report studies the global Anemia Drugs market, analyzes and researches the Anemia Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like GlaxoSmithKline Global Blood Therapeutics (GBT) Bluebird Bio GlycoMimetics Mast Therapeutics Fibrogen Akebia Therapeutics Bayer AG Eli Lilly Regen Biopharma Acceleron Pharma Celgene Corporation Onconova Therapeutics Pieris Pharmaceuticals Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia To Get Sample Copy click here: List of Tables and Figures Figure